Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
276 hedge funds and large institutions have $2.56B invested in Amedisys in 2022 Q4 according to their latest regulatory filings, with 46 funds opening new positions, 97 increasing their positions, 99 reducing their positions, and 53 closing their positions.
2% less repeat investments, than reductions
Existing positions increased: 97 | Existing positions reduced: 99
9% less call options, than puts
Call options by funds: $5.04M | Put options by funds: $5.51M
2.93% less ownership
Funds ownership: 97.39% → 94.46% (-2.9%)
3% less funds holding
Funds holding: 286 → 276 (-10)
13% less first-time investments, than exits
New positions opened: 46 | Existing positions closed: 53
16% less capital invested
Capital invested by funds: $3.06B → $2.56B (-$494M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$70M |
| 2 |
Millennium Management
New York
|
+$32.4M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$23.9M |
| 4 |
VLKIM
Van Lanschot Kempen Investment Management
Amsterdam,
Netherlands
|
+$21.3M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$17.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$46.8M |
| 2 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$36.2M |
| 3 |
Impax Asset Management Group
London,
United Kingdom
|
-$34.9M |
| 4 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$31.5M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$31.1M |
AMED Hedge Fund Activity: Q4 2022 in Review
276 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q4 2022, worth a combined $2.56B — down 16% from $3.06B a quarter earlier.
Sellers outnumbered buyers: 53 funds closed out of AMED and 46 opened new positions — a net loss of 7 holders — while 99 trimmed existing stakes and 97 added.
The largest buyer was Deerfield Management, adding an estimated $70M. The largest seller was Point72 Asset Management, cutting an estimated $46.8M.
- 276 institutional investors held Amedisys (AMED) as of Q4 2022, down from 286 in Q3 2022.
- Funds reported $2.56B of Amedisys stock for Q4 2022, down 16% quarter-over-quarter.
- 46 funds opened new Amedisys positions in Q4 2022 and 53 closed out, a net change of -7 holders.
- The largest Amedisys buyer in Q4 2022 was Deerfield Management, an estimated $70M added.
- The largest Amedisys seller in Q4 2022 was Point72 Asset Management, an estimated $46.8M sold.
Based on aggregated 13F filings for Q4 2022.